Collegium Pharmaceutical Inc reports results for the quarter ended in September 30 - Earnings Summary

• Collegium Pharmaceutical Inc COLL.OQ reported quarterly adjusted earnings of $1.61​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 53 cents. The mean expectation of five analysts for the quarter was for earnings of $1.59 per share. Wall Street expected results to range from $1.45 to $1.84 per share.

• Revenue rose 16.5% to $159.30 million from a year ago; analysts expected $155.57 million.

• Collegium Pharmaceutical Inc's reported EPS for the quarter was 27 cents​.

• The company reported quarterly net income of $9.34 million.

• Collegium Pharmaceutical Inc shares had fallen by 10.2% this quarter and gained 12.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.8% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Collegium Pharmaceutical Inc is 43.00

This summary was machine generated from LSEG data November 8 at 05:16 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)